Using data science to forecast clinical trial outcomes
By
MIT Sloan and CSAIL researchers apply artificial intelligence techniques to one of the largest datasets of clinical trial outcomes to handicap the drug and device approval process
By
MIT Sloan and CSAIL researchers apply artificial intelligence techniques to one of the largest datasets of clinical trial outcomes to handicap the drug and device approval process
We push the boundaries of finance to solve complex problems and fuel progress in the world through the MIT finance ecosystem – a unique global network of people, programs, research, and partnerships.
By
Since its inception, the program has helped launch 70 thriving companies
By
The MIT Laboratory for Financial Engineering (LFE) and Informa Pharma Intelligence announced a new initiative, Project ALPHA (Analytics for Life-sciences Professionals and Healthcare Advocates).
By
Wharton’s Ethan Mollick and MIT Sloan’s Bill Aulet discuss the ways generative artificial intelligence is remaking the competitive landscape of entrepreneurship.
By
In a new book, MIT roboticist Daniela Rus looks at the powers and limitations of robots and how humans can work with them to unlock new capabilities.
By
AI is a tool to get things done. To use it properly and generate value, organizations need the right capabilities — including a good understanding of data.
Twelve teams of students and postdocs across the MIT community presented innovative startup ideas with potential for real-world impact.
Driven by deeply personal experiences, three entrepreneurs find inspiration from MIT to empower patients and change their lives.
By
For the 23 student-led teams in the MIT delta v 2023 cohort, Demo Day marked the end of their journey through the three-month educational accelerator and their first steps out into the world.